USE OF RECOMBINANT OR SYNTHETIC GELATIN-LIKE PROTEINS AS STABILISER IN LYOPHILIZED PHARMACEUTICAL COMPOSITIONS

摘要

The invention relates to the use of gelatin-like proteins, or polypeptides, with an increased calculated glass transition temperature as stabilisers in lyophilized biological or pharmaceutical compositions.